HPV vaccine comprising peptides from host cell proteins

Details for Australian Patent Application No. 2005268646 (hide)

Owner University College Cardiff Consultants Limited

Inventors Man, Stephen Tze Kwung

Agent Griffith Hack

Pub. Number AU-B-2005268646

PCT Pub. Number WO2006/013336

Priority 0417430.6 05.08.04 GB

Filing date 27 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 6 January 2011

International Classifications

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/013336 Priority application(s): WO2006/013336

9 August 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 25 Jan 2007

16 December 2010 Alteration of Name

  The name of the applicant has been altered to University College Cardiff Consultants Limited Amendments

6 January 2011 Application Accepted

  Published as AU-B-2005268646

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268647-Tissue-adhesive materials

2005268645-Stabilised prostaglandin composition